New Alzheimer's drugs targeting brain amyloid show minimal real-world benefits, a major review found. While plaque reduction ...
A new $30 million Brain Health Center at USC in Columbia will be a magnet for advanced diagnosis and treatment of Alzheimer’s ...
The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein ...
A systematic review suggested that drugs targeting amyloid beta appeared to have no clinically meaningful positive effects, ...
Alzheimer's Society responds to the claim that amyloid-targeting drugs show no clinically meaningful positive effects.
Alzheimer’s “wonder drugs” do not work, scientists have found in a study that overturns decades of research into the disease.
The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...
Gates is a supporter of Alzheimer’s research, but scammers are using his name and likeness to promote fraudulent “cures” for ...
A new study has found that combining the current medications for Alzheimer's disease with small molecules derived from ...
Critics say the meta-analysis provides an inaccurate picture of anti-amyloid medications. Two of them have FDA approval.
By Dennis Thompson HealthDay ReporterTHURSDAY, April 16, 2026 (HealthDay News) — New anti-amyloid drugs approved to treat ...
ALZHEIMER drugs hailed as the first-ever dementia treatments do not work, a major review claims. But critics say the report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results